2026 was a highly dynamic year for life sciences, defined by blockbuster-driven growth, faster competitive cycles, and continued policy and pricing disruption. In this Masterclass session, Luke Greenwalt will deliver a recap of the year's defining shifts and what they reveal about how the industry is evolving.

Luke will revisit the most consequential 2026 storylines, such as the continued outsized impact of mega-brands and shifting gross-to-net dynamics, intensifying market access pressure, heightened promotional noise in specialty categories, and the accelerating rise of the patient as informed consumers. This session offers a synthesis of 2026, designed to help leaders align on what happened, why it mattered, and which signals are most important to carry forward.

Key learnings:

• Understand the commercial and competitive dynamics that most defined life sciences performance in 2026
• Examine where launch and promotion dynamics tightened in 2026 as competition intensity, market complexity, and cost per prescriber activation increased
• Assess how "patient as consumer" accelerated in 2026, what it meant for engagement models and services Explore how pricing, policy, and market access pressure showed up in marketplace behavior in 2026.